| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000435 | EBV | ENSG00000133800.9 | protein_coding | LYVE1 | No | No | 10894 | Q9Y5Y7 |
| TVIS10045926 | HBV | ENSG00000133800.9 | protein_coding | LYVE1 | No | No | 10894 | Q9Y5Y7 |
| TVIS30080077 | HIV | ENSG00000133800.9 | protein_coding | LYVE1 | No | No | 10894 | Q9Y5Y7 |
| TVIS20009914 | HPV | ENSG00000133800.9 | protein_coding | LYVE1 | No | No | 10894 | Q9Y5Y7 |
| TVIS20040374 | HPV | ENSG00000133800.9 | protein_coding | LYVE1 | No | No | 10894 | Q9Y5Y7 |
| TVIS20049463 | HPV | ENSG00000133800.9 | protein_coding | LYVE1 | No | No | 10894 | Q9Y5Y7 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | LYVE1 |
|---|---|
| DrugBank ID | DB08818 |
| Drug Name | Hyaluronic acid |
| Target ID | BE0010044 |
| UniProt ID | Q9Y5Y7 |
| Regulation Type | |
| PubMed IDs | 31294035; 26823460 |
| Citations | Gupta RC, Lall R, Srivastava A, Sinha A: Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Front Vet Sci. 2019 Jun 25;6:192. doi: 10.3389/fvets.2019.00192. eCollection 2019.@@Lawrance W, Banerji S, Day AJ, Bhattacharjee S, Jackson DG: Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization. J Biol Chem. 2016 Apr 8;291(15):8014-30. doi: 10.1074/jbc.M115.708305. Epub 2016 Jan 28. |
| Groups | Approved; Vet_approved |
| Direct Classification | Acylaminosugars |
| SMILES | CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O |
| Pathways | |
| PharmGKB | PA165958431 |
| ChEMBL |
